|
|
Article: CDC Observes Reduction in Rotavirus Disease After the Introduction of ROTATEQ(R), Merck's Rotavirus Vaccine.
- Article from:
- Business Wire
- Article date:
- June 25, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc., maker of ROTATEQ([R]) (rotavirus vaccine, live, oral, pentavalent), is pleased that the U.S. Centers for Disease Control and Prevention's (CDC) report shows that rotavirus disease was dramatically reduced in the U.S. from November 2007 through May 2008 compared to previous years. Further monitoring and investigation are needed to assess whether the observed reduction in rotavirus disease reported by the CDC is related to the use of ROTATEQ([R]).
Data from two different surveillance systems showed that in this ongoing rotavirus season, compared to previous years, there was a marked reduction in the number of positive ...